HIV-1 infection and cognitive impairment in the cART era: a review
With the introduction of combination antiretroviral therapy AIDS dementia complex or HIV-
associated dementia, as it was termed later, largely disappeared in clinical practice …
associated dementia, as it was termed later, largely disappeared in clinical practice …
Pathogenesis of HIV in the central nervous system
V Valcour, P Sithinamsuwan, S Letendre… - Current HIV/AIDS …, 2011 - Springer
HIV can infect the brain and impair central nervous system (CNS) function. Combination
antiretroviral therapy (cART) has not eradicated CNS complications. HIV-associated …
antiretroviral therapy (cART) has not eradicated CNS complications. HIV-associated …
Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment
J Harezlak, S Buchthal, M Taylor, G Schifitto, J Zhong… - Aids, 2011 - journals.lww.com
Objective: To determine whether cognitive impairment and brain injury as measured by
proton magnetic resonance spectroscopy (MRS) persist in the setting of HAART. Design …
proton magnetic resonance spectroscopy (MRS) persist in the setting of HAART. Design …
[HTML][HTML] Neurologic complications of HIV disease and their treatment
Findings on the nervous system complications of HIV disease and their impact on people
living with HIV continue to accumulate. New reports at the 17 th Conference on Retroviruses …
living with HIV continue to accumulate. New reports at the 17 th Conference on Retroviruses …
Role of obesity, metabolic variables, and diabetes in HIV-associated neurocognitive disorder
JA McCutchan, JA Marquie-Beck, CA Fitzsimons… - Neurology, 2012 - AAN Enterprises
Objective: To evaluate relationships between HIV-associated neurocognitive disorder and
metabolic variables in a subgroup of HIV+ participants examined in a prospective …
metabolic variables in a subgroup of HIV+ participants examined in a prospective …
[HTML][HTML] HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities
EM Tedaldi, NL Minniti, T Fischer - BioMed research international, 2015 - ncbi.nlm.nih.gov
The prevalence of HIV (human immunodeficiency virus) associated neurocognitive
disorders (HAND) will undoubtedly increase with the improved longevity of HIV-infected …
disorders (HAND) will undoubtedly increase with the improved longevity of HIV-infected …
Neuropsychological functioning and antiretroviral treatment in HIV/AIDS: a review
LA Cysique, BJ Brew - Neuropsychology review, 2009 - Springer
This article presents a review of studies that have investigated the neuropsychological
effects of antiretroviral treatment (ART) for HIV-1 infection. It provides a brief overview of the …
effects of antiretroviral treatment (ART) for HIV-1 infection. It provides a brief overview of the …
Cognitive health in persons with human immunodeficiency virus: the impact of early treatment, comorbidities, and aging
HL Aung, J Alagaratnam, P Chan… - The Journal of …, 2023 - academic.oup.com
With the advent of virally suppressive antiretroviral therapy (ART), life expectancy for
persons with human immunodeficiency virus (HIV) with access to ART now approaches that …
persons with human immunodeficiency virus (HIV) with access to ART now approaches that …
Twelve-year neurocognitive decline in HIV is associated with comorbidities, not age: a CHARTER study
Modern antiretroviral therapy (ART) has increased longevity of people with HIV and shifted
the age distribution of the HIV pandemic upward toward that of the general population. This …
the age distribution of the HIV pandemic upward toward that of the general population. This …
HIV-associated neurocognitive disorder
RC Smail, BJ Brew - Handbook of clinical neurology, 2018 - Elsevier
Human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND) affects
roughly half the HIV-positive population. The symptoms of cognitive slowing, poor …
roughly half the HIV-positive population. The symptoms of cognitive slowing, poor …